# Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment

**Authors:** Adam A. Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, Subash Baniya, Zachary A. Cooper, Adriano Piris, Leeza Hargreaves, Vivien Igras, Dennie T. Frederick, Donald P. Lawrence, Daniel A. Haber, Keith T. Flaherty, Jennifer A. Wargo, Sridhar Ramaswamy, Cyril H. Benes, David E. Fisher

PMC · DOI: 10.1371/journal.pone.0306658 · 2024-07-01

## Full-text entities

- **Genes:** KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, PDGFRB (platelet derived growth factor receptor beta) [NCBI Gene 5159] {aka CD140B, IBGC4, IMF1, JTK12, KOGS, OPDKD}
- **Diseases:** Cancer (MESH:D009369), Melanoma (MESH:D008545)

---
Source: https://tomesphere.com/paper/PMC11216593